AU2002334103A1 - Azabicyclic spiroether derivatives as receptor antagonists - Google Patents

Azabicyclic spiroether derivatives as receptor antagonists

Info

Publication number
AU2002334103A1
AU2002334103A1 AU2002334103A AU2002334103A AU2002334103A1 AU 2002334103 A1 AU2002334103 A1 AU 2002334103A1 AU 2002334103 A AU2002334103 A AU 2002334103A AU 2002334103 A AU2002334103 A AU 2002334103A AU 2002334103 A1 AU2002334103 A1 AU 2002334103A1
Authority
AU
Australia
Prior art keywords
spiroether
azabicyclic
derivatives
receptor antagonists
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002334103A
Other languages
English (en)
Inventor
Ian Thomas Huscroft
Janusz Jozef Kulagowski
Piotr Antoni Raubo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Publication of AU2002334103A1 publication Critical patent/AU2002334103A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002334103A 2002-10-04 2002-10-04 Azabicyclic spiroether derivatives as receptor antagonists Abandoned AU2002334103A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2002/004523 WO2004031191A1 (fr) 2002-10-04 2002-10-04 Derives de spiroether azabicyclique utilises en tant qu'antagonistes du recepteur nk-1

Publications (1)

Publication Number Publication Date
AU2002334103A1 true AU2002334103A1 (en) 2004-04-23

Family

ID=32050695

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002334103A Abandoned AU2002334103A1 (en) 2002-10-04 2002-10-04 Azabicyclic spiroether derivatives as receptor antagonists

Country Status (4)

Country Link
EP (1) EP1551846A1 (fr)
JP (1) JP2006503859A (fr)
AU (1) AU2002334103A1 (fr)
WO (1) WO2004031191A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ329807A (en) * 1997-04-23 2000-07-28 Pfizer NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
US6387925B1 (en) * 1999-06-01 2002-05-14 Pfizer Inc. Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions
US6262067B1 (en) * 1999-06-22 2001-07-17 Pfizer Inc. Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions

Also Published As

Publication number Publication date
JP2006503859A (ja) 2006-02-02
WO2004031191A1 (fr) 2004-04-15
EP1551846A1 (fr) 2005-07-13

Similar Documents

Publication Publication Date Title
AU2003261392A1 (en) M3muscarinic acetylcholine receptor antagonists
AU2003241836A1 (en) Lpa receptor antagonists
AP1828A (en) Muscarinic Acetycholine receptor antagonists
AU2003299807A1 (en) Heteroarylalkanoic acids as integrin receptor antagonists
IL198122A0 (en) Triazole derivatives as tachykinin receptor antagonists
AU2003301851A1 (en) Azacyclic compounds as orexin receptor antagonist
AU2005234596A8 (en) Piperazinylpiperidine derivatives as chemokine receptor antagonists
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
AU2003255501A1 (en) Cxcr4 receptor antagonists
AU2003215549A1 (en) Mercaptoimidazoles as ccr2 receptor antagonists
AU2003267088A1 (en) Chemokine receptor antagonists as therapeutic agents
PL1636206T3 (pl) Pochodne imidazolu jako antagoniści receptorów glutaminianu
IL164016A0 (en) Azetidine derivatives as ccr-3 receptor antagonists
AU2002356369A1 (en) Xanthine derivatives as muscarinic receptor antagonists
AU2003205964A1 (en) Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
AU2002347552A1 (en) 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
AU2003214520A1 (en) Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
AU2003300904A1 (en) Antagonists for human prolactin
AU2003240705A1 (en) Morpholinylmethylureas ccr-3 receptor antagonists
AU2003223010A1 (en) Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
GB0203412D0 (en) 5-HT 2B receptor antagonists
AU2003287219A1 (en) Il-8 receptor antagonists
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
AU2003267802A1 (en) Quaternary ammonium compounds as muscarinic receptor antagonists
AU2003297408A1 (en) Thiazole compounds as integrin receptor antagonists derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase